{"id":"refresh-liquigel","safety":{"commonSideEffects":[{"rate":null,"effect":"Blurred vision"},{"rate":null,"effect":"Eye irritation or discomfort"},{"rate":null,"effect":"Mild stinging upon instillation"}]},"_chembl":null,"_dailymed":{"setId":"4b8b2f6a-4b89-446c-9e5b-9b83c453a01d","title":"REFRESH LIQUIGEL (CARBOXYMETHYLCELLULOSE SODIUM) GEL [ALLERGAN, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The product is a lubricating eye gel containing carboxymethylcellulose sodium as its active ingredient. It adheres to the ocular surface and provides prolonged moisture retention, reducing friction and protecting the cornea and conjunctiva from irritation associated with dry eye disease. The gel formulation allows for extended contact time compared to aqueous solutions.","oneSentence":"REFRESH Liquigel provides ocular lubrication and protection by forming a viscous gel layer on the corneal surface to relieve dry eye symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:31:51.872Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome / keratoconjunctivitis sicca"}]},"trialDetails":[{"nctId":"NCT05425004","phase":"PHASE2","title":"Cabozantinib for Patients With Recurrent or Progressive Meningioma","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2022-06-01","conditions":"Meningioma","enrollment":24},{"nctId":"NCT05249556","phase":"PHASE3","title":"Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old","status":"NOT_YET_RECRUITING","sponsor":"Immedica Pharma AB","startDate":"2026-06","conditions":"CDKL5 Deficiency Disorder","enrollment":20},{"nctId":"NCT01720836","phase":"PHASE1, PHASE2","title":"Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"Olivera Finn","startDate":"2012-11","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":30},{"nctId":"NCT04734652","phase":"PHASE2","title":"INSTI's For The Management of HIV-associated TB","status":"COMPLETED","sponsor":"Centre for the AIDS Programme of Research in South Africa","startDate":"2022-02-18","conditions":"HIV/AIDS, Tuberculosis, Pulmonary","enrollment":122},{"nctId":"NCT07202117","phase":"PHASE4","title":"PLLA and CaHA-R for Aesthetic Rejuvenation","status":"RECRUITING","sponsor":"Erevna Innovations Inc.","startDate":"2025-11-01","conditions":"Aesthetic","enrollment":45},{"nctId":"NCT07153822","phase":"NA","title":"Efficacy and Safety of Ionized Atelocollagen Adhesion Barrier (Collabarrier®) in Spine Surgery","status":"COMPLETED","sponsor":"DALIM TISSEN Co., Ltd.","startDate":"2022-12-15","conditions":"Lumbar Spinal Stenosis, Lumbar Disc Herniation, Epidural Fibrosis","enrollment":69},{"nctId":"NCT07162818","phase":"PHASE4","title":"Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Proliferative Vitreoretinopathy","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2021-04-28","conditions":"Proliferative Vitreoretinopathy, Rhegmatogenous Retinal Detachment","enrollment":61},{"nctId":"NCT06984835","phase":"NA","title":"Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds","status":"RECRUITING","sponsor":"AQTIS Medical B.V.","startDate":"2025-03-31","conditions":"Nasolabial Folds","enrollment":126},{"nctId":"NCT05127824","phase":"PHASE2","title":"Autologous Dendritic Cell Vaccine in Kidney Cancer","status":"RECRUITING","sponsor":"Jodi Maranchie","startDate":"2023-07-06","conditions":"Carcinoma, Renal Cell","enrollment":42},{"nctId":"NCT05813496","phase":"PHASE4","title":"Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt","status":"COMPLETED","sponsor":"Eva Pharma","startDate":"2022-10-26","conditions":"Polyneuropathy, Diabetic","enrollment":430},{"nctId":"NCT06885775","phase":"PHASE2","title":"Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds","status":"NOT_YET_RECRUITING","sponsor":"DEXLEVO","startDate":"2025-04-28","conditions":"Dermal Fillers, Nasolabial Folds, Wrinkles","enrollment":80},{"nctId":"NCT06375343","phase":"PHASE1","title":"Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®","status":"NOT_YET_RECRUITING","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2026-01-30","conditions":"Dry Eye Disease, Dry Eye Sensation, Ocular Surface Disease","enrollment":32},{"nctId":"NCT06731725","phase":"NA","title":"Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye","status":"COMPLETED","sponsor":"i+Med S.Coop.","startDate":"2021-02-17","conditions":"Dry Eye, Dry Eye Syndrome (DES)","enrollment":20},{"nctId":"NCT06576245","phase":"NA","title":"Efficacy of Quantum Molecular Resonance Combined With Intense Pulsed Light in Mixed Dry Eye","status":"COMPLETED","sponsor":"University of Seville","startDate":"2023-09-01","conditions":"Dry Eye","enrollment":25},{"nctId":"NCT00565643","phase":"PHASE4","title":"Seprafilm® Adhesion Barrier and Cesarean Delivery","status":"COMPLETED","sponsor":"Winthrop University Hospital","startDate":"2007-11","conditions":"Adhesions, Cesarean Section, Delivery, Obstetric","enrollment":753},{"nctId":"NCT06343077","phase":"PHASE2","title":"Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance","status":"RECRUITING","sponsor":"Ashutosh Kumar Tewari","startDate":"2024-01-16","conditions":"Prostate Cancer Patients on Active Surveillance","enrollment":114},{"nctId":"NCT06221345","phase":"PHASE4","title":"Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-12-07","conditions":"Dry Eye Disease, Cataract","enrollment":70},{"nctId":"NCT03734211","phase":"PHASE3","title":"Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients","status":"COMPLETED","sponsor":"Lars Gullestad","startDate":"2019-06-10","conditions":"Cardiac Allograft Vasculopathy","enrollment":130},{"nctId":"NCT02340962","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection","status":"COMPLETED","sponsor":"TaiGen Biotechnology Co., Ltd.","startDate":"2015-05","conditions":"Hepatitis C, Chronic","enrollment":25},{"nctId":"NCT03262103","phase":"PHASE1","title":"Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer","status":"COMPLETED","sponsor":"Ashutosh Kumar Tewari","startDate":"2017-06-16","conditions":"Prostate Cancer","enrollment":13},{"nctId":"NCT04302896","phase":"EARLY_PHASE1","title":"Development of a Urine-Based Point-of-Care Test for Adherence to Antiretroviral Drugs","status":"COMPLETED","sponsor":"Rhonda Brand","startDate":"2020-08-31","conditions":"Medication Adherence, HIV","enrollment":30},{"nctId":"NCT04749940","phase":"NA","title":"PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site","status":"WITHDRAWN","sponsor":"Rambam Health Care Campus","startDate":"2021-01-01","conditions":"Treatment of Skin Graft Donor Site","enrollment":""},{"nctId":"NCT04172740","phase":"NA","title":"RADIESSE Injection in Perioral and Marionette Lines","status":"COMPLETED","sponsor":"Erevna Innovations Inc.","startDate":"2019-11-13","conditions":"Skin Quality","enrollment":10},{"nctId":"NCT01467986","phase":"PHASE2","title":"Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma","status":"COMPLETED","sponsor":"University of Regensburg","startDate":"2013-08","conditions":"Neuroblastoma Recurrent","enrollment":130},{"nctId":"NCT01996826","phase":"PHASE1, PHASE2","title":"A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival","status":"COMPLETED","sponsor":"Reza Dana, MD","startDate":"2014-04","conditions":"Corneal Neovascularization, Corneal Graft Failure","enrollment":75},{"nctId":"NCT04485533","phase":"NA","title":"Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED","status":"UNKNOWN","sponsor":"VISUfarma SpA","startDate":"2020-07-06","conditions":"Dry Eye Syndromes","enrollment":90},{"nctId":"NCT03190447","phase":"NA","title":"Wich is the Best Dressing in Wounds by Primary Surgery of THA and / or TKA?","status":"COMPLETED","sponsor":"Corporacion Parc Tauli","startDate":"2017-04-20","conditions":"Occlusive Dressings, Nursing, Knee Surgery","enrollment":560},{"nctId":"NCT03185871","phase":"PHASE2","title":"Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses","status":"WITHDRAWN","sponsor":"University of Wisconsin, Madison","startDate":"2017-09-20","conditions":"Breast Carcinoma","enrollment":""},{"nctId":"NCT02517931","phase":"NA","title":"Sphenopalatine Ganglion Block for Postdural Puncture Headache in the Emergency Department","status":"WITHDRAWN","sponsor":"University of Arkansas","startDate":"2019-01-01","conditions":"Postdural Puncture Headache","enrollment":""},{"nctId":"NCT02117687","phase":"PHASE4","title":"A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-05-14","conditions":"Dry Eye Syndromes, Keratoconjunctivitis Sicca","enrollment":80},{"nctId":"NCT02121847","phase":"PHASE4","title":"Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-04-03","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT02280473","phase":"PHASE3","title":"A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-11-13","conditions":"Dry Eye Syndromes","enrollment":188},{"nctId":"NCT01459588","phase":"PHASE3","title":"Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-10-01","conditions":"Dry Eye Syndromes","enrollment":315},{"nctId":"NCT01844388","phase":"PHASE3","title":"A Study to Compare a New Eye Drop Formulation With Refresh Contacts®","status":"COMPLETED","sponsor":"Allergan","startDate":"2013-05-29","conditions":"Contact Lens Lubrication","enrollment":365},{"nctId":"NCT01294384","phase":"PHASE3","title":"Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-05-01","conditions":"Dry Eye Syndromes","enrollment":305},{"nctId":"NCT01886690","phase":"PHASE3","title":"A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery","status":"COMPLETED","sponsor":"Allergan","startDate":"2013-08-20","conditions":"Bilateral LASIK Surgery","enrollment":148},{"nctId":"NCT03700580","phase":"PHASE2","title":"Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer","status":"COMPLETED","sponsor":"Carlos E Salas","startDate":"2012-08-15","conditions":"Diabetic Foot, Neuropathy, Diabetic, Foot Ulcer","enrollment":50},{"nctId":"NCT01072357","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival","status":"COMPLETED","sponsor":"Reza Dana, MD","startDate":"2009-12","conditions":"Corneal Neovascularization, Corneal Graft Failure","enrollment":30},{"nctId":"NCT01079741","phase":"PHASE1, PHASE2","title":"Safety Study of Adjuvant Vaccine to Treat Melanoma Patients","status":"COMPLETED","sponsor":"Nina Bhardwaj","startDate":"2010-09","conditions":"Melanoma","enrollment":34},{"nctId":"NCT03093129","phase":"PHASE2","title":"Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer (NeoART-V)","status":"UNKNOWN","sponsor":"The 108 Military Central Hospital","startDate":"2018-01-08","conditions":"Colorectal Cancer","enrollment":200},{"nctId":"NCT01793935","phase":"NA","title":"Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia","status":"COMPLETED","sponsor":"K.N. Roy Chengappa","startDate":"2013-04","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":68},{"nctId":"NCT03153735","phase":"NA","title":"Clinical Study to CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement","status":"COMPLETED","sponsor":"CHA MEDITECH Co., Ltd.","startDate":"2016-12-02","conditions":"Small Penis, Penile Enhancement","enrollment":68},{"nctId":"NCT02553772","phase":"PHASE3","title":"A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.","status":"COMPLETED","sponsor":"Allergan","startDate":"2016-01-06","conditions":"Dry Eye Syndromes","enrollment":242},{"nctId":"NCT03140111","phase":"NA","title":"LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients","status":"UNKNOWN","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2017-10-16","conditions":"Dry Eye Syndromes, Primary Sjögren Syndrome","enrollment":12},{"nctId":"NCT03052140","phase":"NA","title":"Lamelleye vs Comparator for the Treatment of Dry Eye Disease","status":"COMPLETED","sponsor":"Glasgow Caledonian University","startDate":"2017-02-21","conditions":"Dry Eye Syndromes","enrollment":31},{"nctId":"NCT02455050","phase":"PHASE3","title":"A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-12","conditions":"Dry Eye Syndromes","enrollment":79},{"nctId":"NCT02353507","phase":"PHASE4","title":"Comparison of Chitosan and Carboxymethylcellulose Silver Dressings on Burn Wounds in Pediatric and Adult Subjects","status":"WITHDRAWN","sponsor":"Medline Industries","startDate":"2015-02","conditions":"Bandages","enrollment":""},{"nctId":"NCT00932477","phase":"NA","title":"Safety and Tolerability of Artificial Tears in Dry Eye Subjects","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-08","conditions":"Dry Eye Syndrome","enrollment":47},{"nctId":"NCT01010282","phase":"NA","title":"Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-11","conditions":"Dry Eye Syndrome","enrollment":288},{"nctId":"NCT00691197","phase":"PHASE2, PHASE3","title":"Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear","status":"COMPLETED","sponsor":"Allergan","startDate":"2008-03","conditions":"Ametropia","enrollment":246},{"nctId":"NCT01799863","phase":"PHASE2, PHASE3","title":"Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis","status":"COMPLETED","sponsor":"Fundação Altino Ventura","startDate":"2012-06","conditions":"Conjunctivitis, Viral","enrollment":50},{"nctId":"NCT02014922","phase":"PHASE4","title":"A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)","status":"COMPLETED","sponsor":"University of Waterloo","startDate":"2013-12","conditions":"Dry Eye Syndromes","enrollment":33},{"nctId":"NCT01879930","phase":"PHASE4","title":"Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study","status":"TERMINATED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2012-11","conditions":"Chronic Pelvic Pain Syndrome, Bladder Pain Syndrome","enrollment":5},{"nctId":"NCT02028754","phase":"PHASE4","title":"A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-07","conditions":"Dry Eye Syndromes, Cataract","enrollment":180},{"nctId":"NCT00761202","phase":"PHASE4","title":"Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms","status":"COMPLETED","sponsor":"Allergan","startDate":"2007-08","conditions":"Dry Eye Syndromes","enrollment":50},{"nctId":"NCT01591434","phase":"PHASE3","title":"Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers","status":"COMPLETED","sponsor":"ConvaTec Inc.","startDate":"2012-05","conditions":"Leg Ulcer","enrollment":65},{"nctId":"NCT01544283","phase":"PHASE2","title":"Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome","status":"UNKNOWN","sponsor":"Injury Care Medical Center","startDate":"2012-03","conditions":"Shoulder Pain","enrollment":60},{"nctId":"NCT00863239","phase":"PHASE2","title":"Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV","status":"COMPLETED","sponsor":"Biolex Therapeutics, Inc.","startDate":"2009-03","conditions":"Hepatitis C, Chronic","enrollment":116},{"nctId":"NCT00544713","phase":"NA","title":"Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery","status":"COMPLETED","sponsor":"Allergan","startDate":"2007-09","conditions":"Dry Eye Syndrome","enrollment":228},{"nctId":"NCT00756678","phase":"PHASE4","title":"Efficacy and Acceptability of Two Lubricant Eye Drops","status":"COMPLETED","sponsor":"Allergan","startDate":"2008-09","conditions":"Dry Eye Syndromes","enrollment":51},{"nctId":"NCT00938704","phase":"PHASE4","title":"Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-06","conditions":"Dry Eye Syndromes","enrollment":71},{"nctId":"NCT00970697","phase":"PHASE3","title":"Becaplermin Gel for MARTORELL's Hypertensive Leg Ulcers","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2004-01","conditions":"MARTORELL'S ULCER, Hypertensive Leg Ulcer, Necrotic Angiodermatitis","enrollment":64},{"nctId":"NCT00987727","phase":"PHASE4","title":"Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-11","conditions":"Dry Eye Syndromes, Keratoconjunctivitis Sicca","enrollment":82},{"nctId":"NCT01384851","phase":"NA","title":"Efficacy of the Chronic Application of Tear Formulations","status":"UNKNOWN","sponsor":"Glasgow Caledonian University","startDate":"2011-07","conditions":"Dry Eye","enrollment":38},{"nctId":"NCT01062204","phase":"NA","title":"Altrazeal™ Versus Aquacel® Ag for Partial Thickness Skin Donor Sites","status":"COMPLETED","sponsor":"ULURU Inc.","startDate":"2008-05","conditions":"Partial-thickness Skin Donor Sites","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"REFRESH LIQUIGEL®","genericName":"REFRESH LIQUIGEL®","companyName":"Allergan","companyId":"allergan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"REFRESH Liquigel provides ocular lubrication and protection by forming a viscous gel layer on the corneal surface to relieve dry eye symptoms. Used for Dry eye syndrome / keratoconjunctivitis sicca.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}